A*STAR and Flagship Pioneering Partner to Drive Breakthrough Innovation in Health and Sustainability with SGD100 Million Investment

Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Acceler...

October 03, 2024 | Thursday | News
Enara Bio Secures $32.5 Million in Series B Financing, Co-Led by Pfizer Ventures and M Ventures

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapi...

October 03, 2024 | Thursday | News
MSD Acquires CN201 from Curon Biopharmaceutical, Advancing B-cell Disease Treatments

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the completion of the acquisition of CN201 from Curon Biopharmaceutical ...

October 02, 2024 | Wednesday | News
Emmes Secures Major NIH Contract to Lead Clinical Coordinating Center for National Institute on Drug Abuse Trials

Emmes, part of Emmes Group, announced they will provide a Clinical Coordinating Center for the NIH's National Institute on Drug Abuse Clinical Trials &nbs...

September 26, 2024 | Thursday | News
Singular Genomics Receives $12.00 Per Share Acquisition Proposal from Concentra Biosciences

Singular Genomics Systems, a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and cli...

September 20, 2024 | Friday | News
Nuance Pharma Expands Bentrio® Nasal Spray Reach Across East and South East Asia

Altamira Therapeutics announces the extension of its exclusive license with Nuance Pharma to cover Singapore, Malaysia, Thailand, Philippines, Indonesia,...

September 17, 2024 | Tuesday | News
Zydus Lifesciences Enters Exclusive Licensing Deal with Viwit Pharmaceuticals for US Launch of Generic MRI Contrast Agents

Zydus Lifesciences Ltd., a global innovation driven healthcare company announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE has...

September 13, 2024 | Friday | News
Panacea Biotec Secures $20 Million from U.S. DFC to Scale Up World’s First Fully-Liquid Hexavalent Vaccine

Panacea Biotec, a leading global biopharmaceutical company, is thrilled to announce a new milestone in its mission to protect children from life-threaten...

September 12, 2024 | Thursday | News
EQT Private Capital Asia Acquires Controlling Stake in GeBBS Healthcare Solutions to Drive Global Expansion

GeBBS Healthcare Solutions ("GeBBS" or the "Company") specializes in revenue cycle management, health information management (HIM),...

September 09, 2024 | Monday | News
Pharma Nordic AS Expands Bentrio® Distribution to Sweden and Denmark Following Successful Norway Launch

Successful launch of Bentrio by Pharma Nordic AS in Norway in 2024 Exclusive distribution agreement extended to also include Sweden and Denmark Alt...

August 23, 2024 | Friday | News
Emergent BioSolutions Completes $30 Million Sale of Baltimore-Camden Facility to Bora Pharmaceuticals

Emergent BioSolutions Inc.  announced it has completed the sale of its drug product facility in Baltimore-Camden to an affiliate of B...

August 21, 2024 | Wednesday | News
Basilea Pharmaceutica Earns $1.25M Milestone Payment as Cresemba® Sales Surge in Asia Pacific and China

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bac...

August 21, 2024 | Wednesday | News
Parse Biosciences Partners with Prisma Biotech to Expand Single-Cell Sequencing Reach in Asia-Pacific

-Parse Biosciences, a leading provider of cost-effective and scalable solutions for single-cell sequencing, today announced an agreement with the Taiwane...

August 08, 2024 | Thursday | News
Skanray Chooses Tata Elxsi as Strategic Partner to Transform Advanced Surgical Imaging Technology

Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, has chose...

August 05, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close